Quick Takeaways
- ORBIMED ADVISORS LLC filed SCHEDULE 13G/A for Verastem, Inc. Common Stock, par value $0.0001 per share (VSTM).
- Disclosed ownership: 5.6%.
- Date of event: 31 Mar 2025.
ORBIMED ADVISORS LLC - 31 Mar 2025 SCHEDULE 13G/A Report for Verastem, Inc. Common Stock, par value $0.0001 per share (VSTM)
- Filing Manager
- ORBIMED ADVISORS LLC
- Reporting Manager
- OrbiMed Advisors LLC
- Symbol
- VSTM
- Shares outstanding
- 51,115,143 shares
- Disclosed Ownership
- 2,862,448 shares
- Ownership
- 5.6%
- Form type
- SCHEDULE 13G/A
- Filing time
- 15 May 2025, 18:41:11 UTC
- Date of event
- 31 Mar 2025
- Next filing
- 14 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"ORBIMED ADVISORS LLC disclosed 5.6% ownership in Verastem, Inc. Common Stock, par value $0.0001 per share (VSTM) on 31 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 15 May 2025, 18:41.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 5.6% | 2,862,448 | 0 | 2,862,448 | /s/ Carl L. Gordon | Carl L. Gordon / Member |